ArrePath

'The two public health crises - cancer and drug resistant infections - are deeply intertwined.' Without a plan to fight superbugs, the Cancer Moonshot will never achieve liftoff statnews.com/2023/08/03/ant…
#AMR #antimicrobialresistance #antibiotics #cancer #cancermoonshot

ArrePath is looking forward to taking part in #BioInfect2023; @AlderleyPark, UK, 1st Feb 2023, where our CEO, @DrLloyd_P, will be presenting in the 'State of the AMR Nation' panel discussion bionow.co.uk/event/BIONOW14…

A warm welcome to our new SAB members Professors @cwcoley (MIT) and @PaulHergie (U of Illinois), joining Prof. @BeEngelhardt (Stanford) and Todd Black (TB Alliance), chaired by our scientific founder Prof. Zemer Gitai @zgitai1 (Princeton).
Stella team!

arrepath.com/arrepath-appoi…

ArrePath has been chosen to present at @MassBio's first #InnovationWeek! Join our CEO, @DrLloyd_P, who will provide a company overview and update on the application of our AI / ML enabled imaging platform in the discovery of new classes of antibacterials. bit.ly/InnovationWeek…

A very warm welcome to Erin Chinn, our newest Arrenaut!
Erin joins our Data Science team and will apply her expertise in Computer Vision to further develop our AI/ML-enabled imaging platform and its application in drug discovery.
#AI #ML #drugdiscovery #computervision #microscopy